GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 55 filers reported holding GAMIDA CELL LTD in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,324 | -73.3% | 18,761 | -50.1% | 0.00% | – |
| Q2 2023 | $72,492 | -82.1% | 37,561 | -88.0% | 0.00% | -100.0% |
| Q4 2022 | $404,037 | -31.1% | 313,207 | -15.1% | 0.00% | 0.0% |
| Q3 2022 | $586,000 | +47.2% | 368,899 | +64.0% | 0.00% | 0.0% |
| Q2 2022 | $398,000 | -48.3% | 224,931 | +21.1% | 0.00% | 0.0% |
| Q1 2022 | $770,000 | +183.1% | 185,700 | +73.8% | 0.00% | 0.0% |
| Q4 2021 | $272,000 | -81.4% | 106,849 | -71.4% | 0.00% | -83.3% |
| Q3 2021 | $1,463,000 | – | 373,095 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
| Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
| Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
| Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
| FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
| Platform Technology Partners | 45,375 | $291,000 | 0.12% |
| PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
| Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |